Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study-Reference-Cited by-同舟云学术

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

Published:2017-09-06 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pizzuti Laura,Marchetti Paolo,Natoli Clara,Gamucci Teresa,Santini Daniele,Scinto Angelo Fedele,Iezzi Laura,Mentuccia Lucia,D’Onofrio Loretta,Botticelli Andrea,Moscetti Luca,Sperati Francesca,Botti Claudio,Ferranti Francesca,Buglioni Simonetta,Sanguineti Giuseppe,Di Filippo Simona,di Lauro Luigi,Sergi Domenico,Catenaro Teresa,Tomao Silverio,Giordano Antonio,Maugeri-Saccà Marcello,Barba Maddalena^ORCID,Vici Patrizia

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-10061-2.pdf

Reference25 articles.

1. Baselga, J. et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 366, 520–529 (2012).

2. Pritchard, K. I. et al. Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2. Clin Breast Cancer. 13, 421–432 (2013).

3. Noguchi, S. et al. Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer. 21, 703–14 (2014).

4. Yardley, D. A. et al. Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. Adv Ther. 30, 870–84 (2013).

5. Rugo, H. S. et al. Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol. 25, 808–15 (2014).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond;Critical Reviews in Oncology/Hematology;2024-08

2. Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study;International Journal of Cancer;2024-03-06

3. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery;Nutrition and Cancer;2023-10-23

4. Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center;Clinical Breast Cancer;2023-01

5. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis;International Journal of Cancer;2022-10-24